SEC Form 4 · accession 0001209191-18-019703
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Curnutte
Officer — Executive Vice President
Period of report
Mar 12, 2018
Accepted (ET)
Mar 14, 2018 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2018 | M | 5,049 | $8.50 | A | 5,049 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $8.50 | Mar 12, 2018 | M | 5,049 | D | Mar 23, 2011 | Mar 22, 2021 | Common Stock | 5,049 | 0 | D |